Home Newsfeeds Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $65

Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $65

Needham analyst Ami Fadia maintains Harmony Biosciences (NASDAQ:HRMY) with a Buy and raises the price target from $60 to $65.

byBenzinga Newsdesk

November 2, 2022

1 minute read

Needham analyst Ami Fadia maintains Harmony Biosciences (NASDAQ:HRMY) with a Buy and raises the price target from $60 to $65.

Cybersecurity Firm Warns Financially Motivated Cyber Criminals Actively Exploiting Zero-Day Vulnerabilities, Microsoft Patches Bug

By Anusuya Lahiri

April 13, 7:24 AM

Microsoft Corp (NASDAQ:MSFT) has patched a zero-day vulnerability affecting all supported versions of Windows, which per researchers, hackers exploited…

MSFT

BTIG Maintains Buy on Penumbra, Raises Price Target to $240

By Benzinga Newsdesk

December 5, 10:57 AM

BTIG analyst Ryan Zimmerman maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $204 to $240.

PEN

3M Settles US Treasury Probe Over Iran-Related Sales

By Shivani Kumaresan

September 22, 11:11 AM

3M Company (NYSE: MMM), the American multinational conglomerate, is on the hook for a substantial settlement following an investigation by the U.S. Treasury Department.

Precigen Touts Encouraging Data From Autologous UltraCAR-T Cells Manufactured Overnight For Next Day Infusion In Ovarian Cancer

By Vandana Singh

June 6, 11:37 AM

Precigen Inc (NASDAQ:PGEN) presented data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from the Phase…

PGEN

Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $65

Related Posts

Cybersecurity Firm Warns Financially Motivated Cyber Criminals Actively Exploiting Zero-Day Vulnerabilities, Microsoft Patches Bug

BTIG Maintains Buy on Penumbra, Raises Price Target to $240

3M Settles US Treasury Probe Over Iran-Related Sales

Precigen Touts Encouraging Data From Autologous UltraCAR-T Cells Manufactured Overnight For Next Day Infusion In Ovarian Cancer